Exact Mass: 368.0336

Exact Mass Matches: 368.0336

Found 32 metabolites which its exact mass value is equals to given mass value 368.0336, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Orotidylic acid

3-[(2R,3R,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]-2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylic acid

C10H13N2O11P (368.0257)


Orotidylic acid, also known as 5-(dihydrogen phosphate)orotidine or omp, is a member of the class of compounds known as pyrimidine ribonucleoside monophosphates. Pyrimidine ribonucleoside monophosphates are pyrimidine ribobucleotides with monophosphate group linked to the ribose moiety. Orotidylic acid is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Orotidylic acid can be found in a number of food items such as coriander, summer savory, oriental wheat, and sourdough, which makes orotidylic acid a potential biomarker for the consumption of these food products. Orotidylic acid can be found primarily in prostate Tissue, as well as in human prostate tissue. Orotidylic acid exists in all living species, ranging from bacteria to humans. In humans, orotidylic acid is involved in a couple of metabolic pathways, which include glycine and serine metabolism and pyrimidine metabolism. Orotidylic acid is also involved in several metabolic disorders, some of which include dihydropyrimidinase deficiency, dihydropyrimidine dehydrogenase deficiency (DHPD), 3-phosphoglycerate dehydrogenase deficiency, and non ketotic hyperglycinemia. Moreover, orotidylic acid is found to be associated with prostate cancer. Orotidylic acid (OMP), is a pyrimidine nucleotide which is the last intermediate in the biosynthesis of uridine monophosphate. Decarboxylation by Orotidylate decarboxylase affords Uridine 5-phosphate which is the route to Uridine and its derivatives de novo and consequently one of the most important processes in nucleic acid synthesis (Dictionary of Organic Compounds). In humans, the enzyme UMP synthase converts OMP into uridine 5- monophosphate. If UMP synthase is defective, orotic aciduria can result. (Wikipedia). KEIO_ID O015; [MS2] KO009132 KEIO_ID O015

   

Dihydromaldoxin

Dihydromaldoxin

C16H13ClO8 (368.0299)


   

14-Hydroxy-Chloromonilinic acid B|chloromonilinic acid A

14-Hydroxy-Chloromonilinic acid B|chloromonilinic acid A

C16H13ClO8 (368.0299)


   

[3,3,4,4,5,6,6,6-octafluoro-5-(trifluoromethyl)hexyl] prop-2-enoate

[3,3,4,4,5,6,6,6-octafluoro-5-(trifluoromethyl)hexyl] prop-2-enoate

C10H7F11O2 (368.027)


   

Vinyltriphenylphosphonium bromide

Vinyltriphenylphosphonium bromide

C20H18BrP (368.0329)


   

2-hydroxypropanoyloxy(phenyl)mercury

2-hydroxypropanoyloxy(phenyl)mercury

C9H10HgO3 (368.0336)


   

10-(4-chlorophenyl)-7-nitropyrimido[4,5-b]quinoline-2,4-dione

10-(4-chlorophenyl)-7-nitropyrimido[4,5-b]quinoline-2,4-dione

C17H9ClN4O4 (368.0312)


   

2-Amino-5-bromo-N-cyclohexyl-N-methylbenzylamine Dihydrochloride

2-Amino-5-bromo-N-cyclohexyl-N-methylbenzylamine Dihydrochloride

C14H23BrCl2N2 (368.0422)


   

Sulfonfluorescein

Sulfonfluorescein

C19H12O6S (368.0355)


   

2-Butoxypropyl (2,4,5-trichlorophenoxy)acetate

2-Butoxypropyl (2,4,5-trichlorophenoxy)acetate

C15H19Cl3O4 (368.0349)


   

1-Sulfobutyl-3-MethyliMidazoliuM trifluoroMethansulfonate

1-Sulfobutyl-3-MethyliMidazoliuM trifluoroMethansulfonate

C9H15F3N2O6S2 (368.0324)


   

PD168393

4-[(3-Bromophenyl)amino]-6-acrylamidoquinazoline

C17H13BrN4O (368.0273)


C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor

   

1,2-Bis(benzyloxy)-4-bromobenzene

1,2-Bis(benzyloxy)-4-bromobenzene

C20H17BrO2 (368.0412)


   

[3-Amino-6-(2-thienyl)-4-(trifluoromethyl)thieno[2,3-b]pyridin-2-yl](cyclopropyl)methanone

[3-Amino-6-(2-thienyl)-4-(trifluoromethyl)thieno[2,3-b]pyridin-2-yl](cyclopropyl)methanone

C16H11F3N2OS2 (368.0265)


   

(6E)-6-{[5-(benzylthio)-2-furyl]methylene}-5-imino-5,6-dihydro-7H-[1,3,4]thiadiazolo[3,2-a]pyrimidin-7-one

(6E)-6-{[5-(benzylthio)-2-furyl]methylene}-5-imino-5,6-dihydro-7H-[1,3,4]thiadiazolo[3,2-a]pyrimidin-7-one

C17H12N4O2S2 (368.0402)


   

2-[[(5-Anilino-1,3,4-thiadiazol-2-yl)thio]methyl]isoindole-1,3-dione

2-[[(5-Anilino-1,3,4-thiadiazol-2-yl)thio]methyl]isoindole-1,3-dione

C17H12N4O2S2 (368.0402)


   

N-(2-methylsulanyl-1,3-benzothiazol-6-yl)-2-(triluoromethyl)benzamide

N-(2-methylsulanyl-1,3-benzothiazol-6-yl)-2-(triluoromethyl)benzamide

C16H11F3N2OS2 (368.0265)


   

4-bromo-2-[(E)-[(5-phenylpyrimidin-2-yl)hydrazinylidene]methyl]phenol

4-bromo-2-[(E)-[(5-phenylpyrimidin-2-yl)hydrazinylidene]methyl]phenol

C17H13BrN4O (368.0273)


   

2-[(Z)-1-chloro-2-(3-fluorophenyl)ethenyl]-7-(trifluoromethyl)-3H-quinazolin-4-one

2-[(Z)-1-chloro-2-(3-fluorophenyl)ethenyl]-7-(trifluoromethyl)-3H-quinazolin-4-one

C17H9ClF4N2O (368.034)


   

[3,4,5-Trihydroxy-6-(2,4,6-trihydroxyphenyl)oxan-2-yl]methyl hydrogen sulate

[3,4,5-Trihydroxy-6-(2,4,6-trihydroxyphenyl)oxan-2-yl]methyl hydrogen sulate

C12H16O11S (368.0413)


   
   

Orotidine-5-monophosphate

Orotidine-5-monophosphate

C10H13N2O11P (368.0257)


   

Orotidine 5-phosphate

Orotidine 5-phosphate

C10H13N2O11P (368.0257)


A pyrimidine ribonucleoside 5-monophosphate having 6-carboxyuracil as the nucleobase.

   

SLC26A3-IN-2

SLC26A3-IN-2

C19H13ClN2O2S (368.0386)


SLC26A3-IN-2 is an orally active inhibitor of anion exchanger protein SLC26A3 (IC50=360 nM). SLC26A3 belongs to solute carrier (SLC) proteins, and the SLC26 family. SLC26 family has broad anion specificity for chloride, bicarbonate, sulfate and oxalate. SLC26A3 down-regulates in adenoma, DRA, involves in in intestinal absorption of chloride and oxalate. The loss of SLC26A3 function mutations is associated with chloride-losing diarrhea[1].

   

(2e)-3-chloro-3-{5-hydroxy-3-[(1s)-1-hydroxy-2-methoxy-2-oxoethyl]-7-methyl-4-oxochromen-2-yl}prop-2-enoic acid

(2e)-3-chloro-3-{5-hydroxy-3-[(1s)-1-hydroxy-2-methoxy-2-oxoethyl]-7-methyl-4-oxochromen-2-yl}prop-2-enoic acid

C16H13ClO8 (368.0299)


   

(2e)-3-chloro-3-[5-hydroxy-7-(hydroxymethyl)-3-(2-methoxy-2-oxoethyl)-4-oxochromen-2-yl]prop-2-enoic acid

(2e)-3-chloro-3-[5-hydroxy-7-(hydroxymethyl)-3-(2-methoxy-2-oxoethyl)-4-oxochromen-2-yl]prop-2-enoic acid

C16H13ClO8 (368.0299)


   

orotidine 5'-monophosphate

orotidine 5'-monophosphate

C10H13N2O11P (368.0257)


   

3-[(2r,3r,4r,5s)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]-6-hydroxy-2-oxopyrimidine-4-carboxylic acid

3-[(2r,3r,4r,5s)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]-6-hydroxy-2-oxopyrimidine-4-carboxylic acid

C10H13N2O11P (368.0257)


   

3-chloro-3-[5-hydroxy-3-(1-hydroxy-2-methoxy-2-oxoethyl)-7-methyl-4-oxochromen-2-yl]prop-2-enoic acid

3-chloro-3-[5-hydroxy-3-(1-hydroxy-2-methoxy-2-oxoethyl)-7-methyl-4-oxochromen-2-yl]prop-2-enoic acid

C16H13ClO8 (368.0299)


   

2-(2-carboxy-3-hydroxy-5-methylphenoxy)-4-chloro-3-hydroxy-5-methoxybenzoic acid

2-(2-carboxy-3-hydroxy-5-methylphenoxy)-4-chloro-3-hydroxy-5-methoxybenzoic acid

C16H13ClO8 (368.0299)


   

2-[3-chloro-2,4-dihydroxy-6-(methoxycarbonyl)phenoxy]-6-hydroxy-4-methylbenzoic acid

2-[3-chloro-2,4-dihydroxy-6-(methoxycarbonyl)phenoxy]-6-hydroxy-4-methylbenzoic acid

C16H13ClO8 (368.0299)


   

3-chloro-3-[5-hydroxy-7-(hydroxymethyl)-3-(2-methoxy-2-oxoethyl)-4-oxochromen-2-yl]prop-2-enoic acid

3-chloro-3-[5-hydroxy-7-(hydroxymethyl)-3-(2-methoxy-2-oxoethyl)-4-oxochromen-2-yl]prop-2-enoic acid

C16H13ClO8 (368.0299)